Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Kyverna Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing cell therapies for patients with autoimmune diseases. The Company’s lead chimeric antigen receptor (CAR) T-cell therapy candidate, KYV-101, is advancing through clinical development with Phase II trials for stiff person syndrome and myasthenia gravis, and two ongoing multi-center Phase I/II trials for patients with lupus nephritis. KYV-101 is an autologous, fully human CD19 CAR T-cell product candidate incorporating highly potent CD28 co-stimulation. The Company is also harnessing investigator-initiated trials and other KYSA studies, including in multiple sclerosis and systemic sclerosis, to inform the next priority indications for the Company to advance into late-stage development. Its pipeline includes next generation CAR T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.
Find out what a historical investment in KYVERNA THERAPEUTICS would be worth today using our KYTX stock calculator.
Buying KYTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in KYVERNA THERAPEUTICS in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in KYTX
What is the ticker symbol of KYVERNA THERAPEUTICS?
The ticker symbol for KYVERNA THERAPEUTICS is KYTX.
How much is one share of KYTX?
One share of KYTX is valued at $4.37 as of 20 November 2026.
What is the market capitalisation of KYVERNA THERAPEUTICS KYTX?
As of 20 November 2026 KYVERNA THERAPEUTICS has a market cap of $283.23M.
What is the 52-week high for KYVERNA THERAPEUTICS stock?
The KYVERNA THERAPEUTICS 52-week high stock price is $13.67.
What is the 52-week low for KYVERNA THERAPEUTICS stock?
The KYVERNA THERAPEUTICS 52-week low stock price is $4.30.
Can I buy KYTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy KYTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in KYTX on Stake
Buy KYTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of KYTX from only US$10 with fractional shares